Roman Schimmer

6PUBLICATIONS
31CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 06, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Roman R Schimmer, Nancy Klemm, Jonas Fullin

|Dec 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Jonas Fullin, Ebru Topçu, Karolina A Zielińska

|Mar 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect.

Nancy Klemm, Roman R Schimmer, Nils K Konrad

|Feb 14, 2024
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.

Jan Mueller, Roman R Schimmer, Christian Koch

|Jan 03, 2024
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab.

Roman R Schimmer, Tabea Sutter, Adrian Bachofner

|Jan 13, 2022
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms.

Roman R Schimmer, Larisa V Kovtonyuk, Nancy Klemm

Pageof 1

Frequent Collaborators

5 joint publications

Steffen Boettcher

4 joint publications

Kari J Kurppa

4 joint publications

Christian Koch

3 joint publications

Markus G Manz